Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh.
The company produces more than 500 products in different dosage forms. The company was incorporated in 1976 and commenced operations in 1980 with the manufacturing and marketing of products of Bayer AG, Germany and Upjohn Inc., USA under licensing arrangements. In 1983, the company started manufacturing its own formulations and it launched export operation in 1992. Today Beximco Pharma is the lar
gest exporter of pharmaceuticals in the country and the only company to win National Export Trophy (Gold) a record 4 times. The company is the largest producer of Metered Dose Inhalers (MDIs) in the country, and the first to produce CFC free inhalers. BPL is also the first company to produce anti-retroviral drugs (ARVs) locally. As a public limited company, its shares are actively traded in Dhaka Stock Exchange and Chittagong Stock Exchange, and Beximco Pharma has the unique distinction of being the only company in the country listed on AIM of London Stock Exchange. The name Beximco Pharma assures you of many things: outstanding product quality, leading-edge technology, advanced new products, and a commitment to serve the medical community. Our products come in a wide range of dosage forms including tablets, capsules, dry syrup, powder for suspension, cream, ointment, suppositories, metered dose nasal sprays, large volume intravenous fluids, metered dose inhalers etc. ensuring the global standard of quality. Healthcare professionals may contact us directly or alternatively the nearest Beximco Pharma Medical Representatives for further information. Our country regulations do not allow pharmaceutical companies to offer medical advice or guidance to patients. Prescription medicines should be taken only as directed by a registered medical practitioner. Click on the product name for Consumer Medicine Information.
